3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Astrocytoma
8
Glioblastoma
5
Neuroectodermal Tumors, Primitive
3
Recurrence
2
Oligodendroglioma
2
Neurocytoma
2
Lymphoma, Non-Hodgkin
2
Glioma
2
Brain Neoplasms
2
Rhabdoid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Melanoma
1
Lung Neoplasms
1
Gliosarcoma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Ependymoma
1
Craniopharyngioma
1
Carcinoma, Non-Small-Cell Lung
1
Adrenocortical Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
antineoplaston AS 2-1
×
Clear all
No trials found.